Cell Surface Markers Market to Grow with a CAGR of 8.25% through 2028
Rising prevalence of chronic diseases and
expanding biopharmaceutical Industry are factors driving the global Cell
Surface Markers market in the forecast period 2024-2028.
According to
TechSci Research report, “Cell Surface Markers Market – Global Industry
Size, Share, Trends, Competition Forecast & Opportunities, 2028”,
the Global Cell Surface Markers Market stood at USD 797.35 million in 2022 and
is anticipated to grow with a CAGR of 8.25% in the forecast period, 2024-2028. The Global Cell
Surface Markers Market is experiencing remarkable growth, fueled by a multitude
of factors that are driving its expansion. Cell surface markers, also known as
cell surface antigens, play a pivotal role in identifying and characterizing
various cell types, making them invaluable in fields like immunology, oncology,
and drug development.
One
of the primary drivers behind the growth of the Cell Surface Markers Market is
the escalating incidence of chronic diseases worldwide. Conditions such as
cancer, autoimmune disorders, and infectious diseases necessitate advanced
diagnostic and therapeutic tools. Cell surface markers are essential in the
development of targeted therapies, patient stratification, and disease
monitoring, making them indispensable in the fight against chronic diseases.
The continuous
advancement in flow cytometry technology has greatly expanded the utility of
cell surface markers. Modern flow cytometers can analyze multiple parameters
simultaneously, offering high-resolution data on cell populations. This has
boosted the demand for a wider range of cell surface markers and associated
reagents, contributing to market growth.
The
biopharmaceutical industry is experiencing robust growth, driven by the
development of biologics, monoclonal antibodies, and personalized medicine.
Cell surface markers are crucial in drug discovery, target validation, and the
development of biopharmaceuticals. As the biopharmaceutical sector expands, so
does the demand for cell surface markers, further boosting the market. Governments,
academic institutions, and pharmaceutical companies are allocating substantial
resources to research and development initiatives in life sciences. These
investments fuel innovation in cell surface marker technology, leading to the
development of novel markers and improved detection methods. This, in turn,
drives market growth as researchers seek cutting-edge tools for their studies.
The
concept of personalized medicine, which tailors treatments to individual
patients based on their genetic and molecular profiles, is gaining prominence.
Cell surface markers play a critical role in identifying biomarkers and
therapeutic targets for personalized medicine. As awareness of the benefits of
personalized treatments increases, the demand for cell surface markers is
likely to grow significantly. The aging global population is susceptible to a
range of diseases, including cancer, autoimmune disorders, and
neurodegenerative conditions. Cell surface markers are pivotal in diagnosing
and monitoring these diseases. With the elderly population expanding, the
demand for cell surface markers is set to rise in tandem.
Cell
surface markers were initially used primarily in immunology and cancer
research. However, their applications have expanded to include neuroscience,
stem cell research, and regenerative medicine. This diversification of
application areas broadens the market's scope, attracting new customers and
driving growth. Collaborations between research institutions, pharmaceutical
companies, and diagnostic laboratories are fostering innovation in cell surface
marker development. These partnerships facilitate the exchange of expertise,
resources, and technologies, resulting in the introduction of new products and
solutions to the market.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on "Cell Surface Markers Market.”
The Global Cell
Surface Markers Market is segmented into source, product, cell type,
application and company.
Cell surface markers are indispensable in immunophenotyping, which is
the process of characterizing immune cells based on their surface markers. This
technique is widely used in clinical laboratories to diagnose immune-related
disorders, assess immune system function, and monitor the effectiveness of
treatments such as chemotherapy and immunotherapy.
Based on Application,
the clinical segment
has emerged as the predominant market leader..
Based on region,
North America segment is expected to grow during the forecast
period. North America is known for its significant healthcare
expenditure, both in terms of government funding and private investment. This
financial support extends to diagnostic and therapeutic technologies, including
those related to cell surface markers, creating a conducive environment for
market growth. Collaboration
between academic institutions, research organizations, and pharmaceutical
companies in North America has led to the development of novel cell surface
marker-based therapies and diagnostic tools. These collaborations foster
innovation and expand the market's reach.
The Asia Pacific
region is experiencing rapid market growth.
The well-established regulatory framework in the region ensures that
cell surface markers meet rigorous quality and safety standards. This instills
confidence in both domestic and international customers, further enhancing the
region's reputation as a global leader in this market.
Major companies
operating in Global Cell Surface Markers Market are:
- QIAGEN
N.V.
- Becton,
Dickinson and Company.
- Danaher
Corporation
- F.
Hoffmann-La Roche AG
- Bio-Rad
Laboratories, Inc
- Abcam
plc
- GenScript
Biotech Corporation
- BioLegend,
Inc.
- Merck
KGaA.
Download Free Sample Report
Customers can
also request for 10% free customization on this report.
“The Global Cell
Surface Markers Market is on a growth trajectory, driven by an array of
factors, including the rising prevalence of chronic diseases, advancements in
technology, a booming biopharmaceutical industry, increased research
investments, and the growing awareness of personalized medicine. As the market
continues to evolve and expand, it is poised to play a crucial role in the
advancement of diagnostics, therapeutics, and the overall understanding of cell
biology in various research and clinical applications.,” said Mr. Karan Chechi,
Research Director with TechSci Research, a research-based management consulting
firm.
“Cell Surface Markers Market By Source (Mice, Rats), By Product
(Antibodies, PCR Arrays, Others), By Product
(Antibodies, PCR Arrays, Others), By Cell Type ( B Cell Surface Markers,
Monocyte Cell Surface Markers, NK Cell Surface Markers, T Cell Surface Markers),
By Application (Clinical (Immunodeficiency Diseases, Oncology), Research(Drug
Discovery, Immunology, Stem Cell Research)), By Region, By Competition Forecast & Opportunities, 2018-2028F”,
has evaluated the future growth potential of Global Cell Surface Markers Market
and provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Cell Surface Markers Market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: www.techsciresearch.com